Oxygenta Pharma Acquires Land for ₹6.75 Cr for Expansion
Oxygenta Pharmaceutical Ltd has announced the final allotment of a plot of land measuring 36,421 Sq. Mtrs. at UDL-Aroor, Sangareddy District, Telangana, from Telangana Industrial Infrastructure Corporation Limited (TGIIC). The total consideration for this land acquisition is ₹6,75,24,534/- (Rupees Six Crore Seventy-Five Lakh Twenty-Four Thousand Five Hundred and Thirty-Four Only). This strategic acquisition is aimed at supporting the company's business operations, facilitating future expansion, and establishing additional infrastructure to meet long-term strategic requirements. The company expects this move to enhance its operational capabilities and provide adequate infrastructure for anticipated business growth. The transaction's value exceeds the materiality threshold, necessitating this disclosure.
Key Highlights
- Oxygenta Pharma acquires 36,421 Sq. Mtrs. land in Telangana.
- Total consideration for the land purchase is ₹6.75 Crore.
- Acquisition aims to support business operations and future expansion.
- Enhances operational capabilities and infrastructure for growth.
- Transaction value exceeds SEBI's materiality threshold.
Price Impact
More from OXYGENTAPH